Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

on behalf of the; International Network on Hepatitis in Substance Users (INHSU)

doi:10.1016/S2468-1253(17)30284-4

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

on behalf of the
, International Network on Hepatitis in Substance Users (INHSU)

Department of Clinical and Personalized Medicine

University of New South Wales
INHSU
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Helsinki University Central Hospital
Ludwig Maximilian University of Munich
Arud Centre for Addiction Medicine
University of Oslo
Luxembourg Institute of Health
Medical University of Białystok
Queen Mary University of London
Fundeni Clinical Institute
Public Health Scotland
Aristotle University of Thessaloniki
University of Bristol
Ministry of Health
Vilnius University
L. Pastuer University Hospital
Karolinska Institutet
University of Cyprus
Saint Laszlo Hospital
University of Tartu
University of Lisbon
University of Ljubljana
Mid-Western Regional Hospital Limerick
Landspitali University Hospital
University of Southern Denmark
Hôpital Henri Mondor
Mater Dei Hospital
East Limburg Hospital
Hasselt University
KU Leuven
Universitat Autònoma de Barcelona
Military Medical Academy, Sofia
Institute for Clinical and Experimental Medicine
Riga East University Hospital
Office for Public Health
Academic Medical Centre
Medical School University of Zagreb
ISGlobal
University of Copenhagen

Research output: Contribution to journal › Comment/debate/note

133 Citations (Scopus)

Original language	English
Pages (from-to)	125-133
Journal	The Lancet Gastroenterology and Hepatology
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/S2468-1253(17)30284-4
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2468-1253(17)30284-4

Cite this

@article{fd169574339044dbbdbce3c86b4e815d,

title = "Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe",

author = "\{on behalf of the\} and \{International Network on Hepatitis in Substance Users (INHSU)\} and Marshall, \{Alison D.\} and Cunningham, \{Evan B.\} and Stine Nielsen and Alessio Aghemo and Hannu Alho and Markus Backmund and Philip Bruggmann and Olav Dalgard and Carole Seguin-Devaux and Robert Flisiak and Foster, \{Graham R.\} and Liana Gheorghe and David Goldberg and Ioannis Goulis and Matthew Hickman and Patrick Hoffmann and Ligita Jancorienė and Peter Jarcuska and Martin K{\aa}berg and Kostrikis, \{Leondios G.\} and Mih{\'a}ly Makara and Matti Maimets and Marinho, \{Rui Tato\} and Mojca Mati{\v c}i{\v c} and Suzanne Norris and Sigur{\dh}ur {\'O}lafsson and Anne {\O}vrehus and Pawlotsky, \{Jean Michel\} and James Pocock and Geert Robaeys and Carlos Roncero and Marieta Simonova and Jan Sperl and Michele Tait and Ieva Tolmane and Stefan Tomaselli and \{van der Valk\}, Marc and Adriana Vince and Dore, \{Gregory J.\} and Lazarus, \{Jeffrey V.\} and Jason Grebely",

year = "2018",

doi = "10.1016/S2468-1253(17)30284-4",

language = "English",

volume = "3",

pages = "125--133",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

AU - on behalf of the

AU - International Network on Hepatitis in Substance Users (INHSU)

AU - Marshall, Alison D.

AU - Cunningham, Evan B.

AU - Nielsen, Stine

AU - Aghemo, Alessio

AU - Alho, Hannu

AU - Backmund, Markus

AU - Bruggmann, Philip

AU - Dalgard, Olav

AU - Seguin-Devaux, Carole

AU - Flisiak, Robert

AU - Foster, Graham R.

AU - Gheorghe, Liana

AU - Goldberg, David

AU - Goulis, Ioannis

AU - Hickman, Matthew

AU - Hoffmann, Patrick

AU - Jancorienė, Ligita

AU - Jarcuska, Peter

AU - Kåberg, Martin

AU - Kostrikis, Leondios G.

AU - Makara, Mihály

AU - Maimets, Matti

AU - Marinho, Rui Tato

AU - Matičič, Mojca

AU - Norris, Suzanne

AU - Ólafsson, Sigurður

AU - Øvrehus, Anne

AU - Pawlotsky, Jean Michel

AU - Pocock, James

AU - Robaeys, Geert

AU - Roncero, Carlos

AU - Simonova, Marieta

AU - Sperl, Jan

AU - Tait, Michele

AU - Tolmane, Ieva

AU - Tomaselli, Stefan

AU - van der Valk, Marc

AU - Vince, Adriana

AU - Dore, Gregory J.

AU - Lazarus, Jeffrey V.

AU - Grebely, Jason

PY - 2018

Y1 - 2018

UR - https://www.sciencedirect.com/science/article/pii/S2468125317302844

U2 - 10.1016/S2468-1253(17)30284-4

DO - 10.1016/S2468-1253(17)30284-4

M3 - Comment/debate/note

C2 - 28986139

SN - 2468-1253

VL - 3

SP - 125

EP - 133

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 2

ER -

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

UN SDGs

Access to Document

Other files and links

Cite this